Background Recent studies have demonstrated that cytomegalovirus (CMV) infection and
disease are associated with increased risk of graft loss and death in high‐risk (donor CMV …

In the era of effective antiviral chemoprophylaxis, cytomegalovirus (CMV) disease has been
inconsistently associated with increased mortality in liver transplant (LT) recipients. A …

Background. Antiviral prophylaxis has been shown to decrease the incidence of
cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease …

Background. The incidence and impact of cytomegalovirus (CMV) disease that occurs
despite CMV prophylaxis among liver transplant recipients have been incompletely defined …

Cytomegalovirus (CMV) infection is an opportunistic infection frequently found after solid
organ transplantation, and it contributes significantly to mortality and morbidity. CMV …

BACKGROUND: Cytomegalovirus (CMV) infection and related disease is a feared
complication after liver transplantation. Antiviral prophylaxis is recommended in clinical …

Purpose To evaluate epidemiology, risk‐factors, and outcomes of high‐level (HL)
cytomegalovirus (CMV) viremia in liver transplant recipients. Methods Adult patients …

OBJECTIVE To assess the association between cytomegalovirus (CMV) serology of donor
and recipient and adverse outcomes after liver transplantation in the era of effective antiviral …

Cytomegalovirus (CMV) infection is one of the primary causes of morbidity and mortality
following liver transplantation (LT). Based on current worldwide guidelines, the most …

Cytomegalovirus (CMV) is one of the most common viral pathogens causing clinical disease
in liver transplant recipients, and contributing to substantial morbidity and occasional …